Zydus Cadila files investigational new drug application for COVID-19 treatment
Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including COVID-19
Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including COVID-19